Commentary|Articles|October 7, 2026

Using AI to Design Better Trials Before the First Patient Enrolls: Q&A with Claire Riches, Citeline

In this Q&A, Claire Riches, VP of clinical solutions at Citeline, discusses how AI is transforming endpoint selection and protocol pressure-testing, what data inputs matter most for realistic enrollment planning, and why the tools are more accessible than most sponsors assume.

Endpoint selection, inclusion-exclusion criteria, and enrollment assumptions have long been shaped by what a sponsor's internal team has seen before—a bounded view that leaves real risk invisible until a trial is already running. Artificial intelligence (AI) is changing that calculus, and for clinical operations professionals still weighing when and how to engage with these tools, the window for waiting is closing.

Related to this article

Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.